Banka Bioloo Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹83.23Undervalued by 80.93%vs CMP ₹46.00

P/E (15.0) × ROE (24.2%) × BV (₹28.10) × DY (2.00%)

Defaults: P/E=15

₹46.52Fairly Valued by 1.13%vs CMP ₹46.00
MoS: +1.1% (Thin)Confidence: 43/100 (Low)Models: 1 Under, 2 Fair, 1 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹57.2841%Under (+24.5%)
Net Asset ValueAssets₹28.0624%Over (-39%)
ROCE CapitalReturns₹43.7816%Fair (-4.8%)
Revenue MultipleRevenue₹49.6518%Fair (+7.9%)
Consensus (4 models)₹46.52100%Fairly Valued
Key Drivers: EPS CAGR -31.2% drags value — could be higher if earnings stabilize.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -31.2% · Defaults: P/E=15

*Investments are subject to market risks

Analyst Summary

Banka Bioloo Ltd operates in the Infrastructure - General segment, NSE: Code | BSE: Code, current market price is ₹46.00, market cap is 50.2 Cr.. At a glance, ROE is 24.2 %, ROCE is 7.61 %, book value is 28.1, dividend yield is 0.00 %. The latest intrinsic value estimate is ₹46.52, which is broadly in line with the current market price. On operating trend, latest reported sales are about ₹54 Cr versus the prior period change of 8.4%, while latest net profit is about ₹-9 Cr with a prior-period change of -1,229.9%. The 52-week range shown on this page is 97.9/41.0, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisBanka Bioloo Ltd. is a Public Limited Listed company incorporated on 31/08/2012 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L90001…

This summary is generated from the stock page data available for Banka Bioloo Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

53
Banka Bioloo Ltd scores 53/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health55/100 · Moderate
ROCE 7.6% WeakROE 24.2% ExcellentD/E 0.25 Low debtInterest Coverage 0.0x RiskyProfitable 3/5 years Mixed
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 52.2% Stable
Earnings Quality40/100 · Moderate
OPM contracting (14% → 1%) Declining
Quarterly Momentum60/100 · Moderate
Revenue (4Q): -5% YoY FlatOPM: -0.1% (up 36.0% YoY) Margin expansion
Industry Rank60/100 · Moderate
ROCE 7.6% vs industry 9.8% AverageROE 24.2% vs industry 14.4% Above peers3Y sales CAGR: 12% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:41 am

Market Cap 50.2 Cr.
Current Price 46.0
Intrinsic Value₹46.52
High / Low 97.9/41.0
Stock P/E
Book Value 28.1
Dividend Yield0.00 %
ROCE7.61 %
ROE24.2 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Banka Bioloo Ltd

Competitors

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Genus Prime Infra Ltd 32.7 Cr. 21.9 35.4/16.354.5 1570.00 %0.06 %0.09 % 2.00
Ekansh Concepts Ltd 254 Cr. 168 308/96.4688 33.30.00 %4.41 %1.88 % 10.0
Dhruv Consultancy Services Ltd 56.1 Cr. 29.6 80.0/22.2 55.90.68 %11.3 %8.19 % 10.0
Crane Infrastructure Ltd 8.33 Cr. 11.5 24.0/9.1414.6 41.70.00 %2.84 %2.21 % 10.0
Brahmaputra Infrastructure Ltd 448 Cr. 154 179/38.56.69 1090.00 %10.8 %11.0 % 10.0
Industry Average1,557.11 Cr105.1560.1390.100.22%9.84%14.41%8.15

All Competitor Stocks of Banka Bioloo Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 12.3610.718.188.2811.4513.9616.3112.8912.4114.0414.8411.1413.01
Expenses 10.858.497.189.799.1612.1815.2811.1516.8914.0115.0110.8013.02
Operating Profit 1.512.221.00-1.512.291.781.031.74-4.480.03-0.170.34-0.01
OPM % 12.22%20.73%12.22%-18.24%20.00%12.75%6.32%13.50%-36.10%0.21%-1.15%3.05%-0.08%
Other Income 0.150.150.350.180.100.110.120.12-0.230.120.031.060.07
Interest 0.440.470.180.510.680.650.630.870.851.011.030.890.93
Depreciation 0.300.290.580.460.550.570.610.620.620.630.660.640.70
Profit before tax 0.921.610.59-2.301.160.67-0.090.37-6.18-1.49-1.83-0.13-1.57
Tax % 5.43%32.30%98.31%1.30%-5.17%-2.99%166.67%21.62%-0.81%-2.01%-12.02%-100.00%-30.57%
Net Profit 0.881.090.01-2.331.220.69-0.250.29-6.13-1.46-1.610.01-1.08
EPS in Rs 0.811.000.01-2.151.120.65-0.220.27-5.65-1.35-1.490.01-0.99

Last Updated: January 2, 2026, 7:31 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 1:46 pm

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 47.8630.4638.7542.3550.0054.1854.25
Expenses 39.1727.0133.1936.1646.2057.0352.62
Operating Profit 8.693.455.566.193.80-2.851.63
OPM % 18.16%11.33%14.35%14.62%7.60%-5.26%3.00%
Other Income 0.450.580.480.710.490.051.23
Interest 0.831.561.791.792.663.793.76
Depreciation 0.470.600.941.482.192.532.77
Profit before tax 7.841.873.313.63-0.56-9.12-3.67
Tax % 20.66%-17.65%6.04%30.03%19.64%-2.41%
Net Profit 6.232.203.112.54-0.67-8.91-2.81
EPS in Rs 6.052.142.872.34-0.60-8.20-2.61
Dividend Payout % 6.60%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-64.69%41.36%-18.33%-126.38%-1229.85%
Change in YoY Net Profit Growth (%)0.00%106.05%-59.69%-108.05%-1103.47%

Banka Bioloo Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:3%
3 Years:12%
TTM:-4%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-551%
Stock Price CAGR
10 Years:%
5 Years:14%
3 Years:5%
1 Year:-34%
Return on Equity
10 Years:%
5 Years:-1%
3 Years:-6%
Last Year:-24%

Last Updated: September 5, 2025, 12:35 am

Balance Sheet

Last Updated: April 10, 2026, 2:00 am

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 4.1110.2810.8510.8510.8510.8710.88
Reserves 23.9219.7526.6629.2528.8720.6419.74
Borrowings 11.4411.6918.5016.7125.9134.7332.39
Other Liabilities 7.304.648.048.3911.8015.9217.11
Total Liabilities 46.7746.3664.0565.2077.4382.1680.12
Fixed Assets 4.025.096.7710.6815.3915.8625.14
CWIP 0.000.002.423.436.517.640.00
Investments 0.000.020.050.060.020.040.08
Other Assets 42.7541.2554.8151.0355.5158.6254.90
Total Assets 46.7746.3664.0565.2077.4382.1680.12

Reserves and Borrowings Chart

Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -5.565.86-0.447.352.760.87
Cash from Investing Activity + -5.06-4.70-6.68-7.46-10.07-6.02
Cash from Financing Activity + 7.15-3.690.95-3.336.785.08
Net Cash Flow -3.47-2.52-6.16-3.44-0.53-0.07
Free Cash Flow -6.975.35-3.590.94-7.21-3.57
CFO/OP -80%135%4%132%93%-66%

Free Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-2.75-8.24-12.94-10.52-22.11-37.58

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 114.17139.96191.78197.63167.61187.28
Inventory Days 455.71574.51552.18
Days Payable 198.79207.54262.72
Cash Conversion Cycle 114.17139.96448.69564.60457.07187.28
Working Capital Days 148.56243.73246.13176.60155.4972.15
ROCE %8.45%10.44%9.61%3.43%-7.61%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 55.17%55.12%55.87%53.20%52.72%52.72%52.62%52.62%52.44%52.38%52.23%52.20%
FIIs 0.00%0.00%0.00%0.00%0.03%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 44.83%44.88%44.13%46.80%47.25%47.28%47.38%47.38%47.56%47.62%47.77%47.80%
No. of Shareholders 3,6543,7514,0604,4486,2656,0315,7115,7976,1336,0095,6375,512

Shareholding Pattern Chart

No. of Shareholders

Banka Bioloo Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -8.21-0.602.393.022.14
Diluted EPS (Rs.) -8.21-0.592.393.022.14
Cash EPS (Rs.) -5.891.423.703.712.73
Book Value[Excl.RevalReserv]/Share (Rs.) 28.9836.6236.9734.5729.21
Book Value[Incl.RevalReserv]/Share (Rs.) 28.9836.6236.9734.5729.21
Revenue From Operations / Share (Rs.) 49.8246.0939.0435.7329.62
PBDIT / Share (Rs.) -2.343.806.135.503.87
PBIT / Share (Rs.) -4.671.784.764.633.29
PBT / Share (Rs.) -8.42-0.493.343.021.82
Net Profit / Share (Rs.) -8.22-0.592.332.842.15
NP After MI And SOA / Share (Rs.) -8.20-0.602.342.872.14
PBDIT Margin (%) -4.698.2415.6915.3813.07
PBIT Margin (%) -9.363.8612.1912.9511.11
PBT Margin (%) -16.89-1.088.548.466.13
Net Profit Margin (%) -16.49-1.305.987.947.24
NP After MI And SOA Margin (%) -16.45-1.305.998.017.23
Return on Networth / Equity (%) -28.28-1.646.338.287.34
Return on Capital Employeed (%) -11.463.7111.0610.709.10
Return On Assets (%) -10.85-0.843.894.854.75
Long Term Debt / Equity (X) 0.370.270.120.190.19
Total Debt / Equity (X) 1.090.620.370.430.25
Asset Turnover Ratio (%) 0.670.700.650.720.65
Current Ratio (X) 1.411.952.543.073.92
Quick Ratio (X) 1.251.621.772.283.04
Inventory Turnover Ratio (X) 7.694.430.420.831.19
Dividend Payout Ratio (NP) (%) 0.000.000.000.0018.65
Dividend Payout Ratio (CP) (%) 0.000.000.000.0014.67
Earning Retention Ratio (%) 0.000.000.000.0081.35
Cash Earning Retention Ratio (%) 0.000.000.000.0085.33
Interest Coverage Ratio (X) -0.671.674.293.432.63
Interest Coverage Ratio (Post Tax) (X) -1.290.732.642.772.46
Enterprise Value (Cr.) 108.47123.3388.05100.6362.50
EV / Net Operating Revenue (X) 2.002.472.082.602.05
EV / EBITDA (X) -42.6229.9313.2416.8815.70
MarketCap / Net Operating Revenue (X) 1.452.021.792.292.02
Retention Ratios (%) 0.000.000.000.0081.34
Price / BV (X) 2.502.551.892.362.05
Price / Net Operating Revenue (X) 1.452.021.792.292.02
EarningsYield -0.11-0.010.030.030.03

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Banka Bioloo Ltd. is a Public Limited Listed company incorporated on 31/08/2012 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L90001TG2012PLC082811 and registration number is 082811. Currently Company is involved in the business activities of Treatment of waste water or sewer by means of physical, chemical or biological processes. Company's Total Operating Revenue is Rs. 55.00 Cr. and Equity Capital is Rs. 10.87 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Infrastructure - GeneralA 109, Express Apartments, Hyderabad Telangana 500004Contact not found
Management
NamePosition Held
Mr. Sanjay BankaExecutive Chairman
Mrs. Namita Sanjay BankaManaging Director
Mr. Vishal MurarkaExecutive Director & CEO
Mr. Akhilesh Kumar TripathiExecutive Director
Mr. Sanjay Kumar GangwarIndependent Director
Dr. Basava Raju DumpalaIndependent Director
Mrs. Aparajita AgrawalIndependent Director
Mr. Anil SharmaIndependent Director

FAQ

What is the intrinsic value of Banka Bioloo Ltd and is it undervalued?

As of 23 April 2026, Banka Bioloo Ltd's intrinsic value is ₹46.52, which is 1.13% higher than the current market price of ₹46.00, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (24.2 %), book value (₹28.1), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Banka Bioloo Ltd?

Banka Bioloo Ltd is trading at ₹46.00 as of 23 April 2026, with a FY2026-2027 high of ₹97.9 and low of ₹41.0. The stock is currently near its 52-week low. Market cap stands at ₹50.2 Cr..

How does Banka Bioloo Ltd's P/E ratio compare to its industry?

Banka Bioloo Ltd has a P/E ratio of , which is below the industry average of 60.13. This is broadly in line with or below the industry average.

Is Banka Bioloo Ltd financially healthy?

Key indicators for Banka Bioloo Ltd: ROCE of 7.61 % is on the lower side compared to the industry average of 9.84%; ROE of 24.2 % shows strong shareholder returns. Dividend yield is 0.00 %.

Is Banka Bioloo Ltd profitable and how is the profit trend?

Banka Bioloo Ltd reported a net profit of ₹-9 Cr in Mar 2025 on revenue of ₹54 Cr. Compared to ₹3 Cr in Mar 2022, the net profit shows a declining trend.

Does Banka Bioloo Ltd pay dividends?

Banka Bioloo Ltd has a dividend yield of 0.00 % at the current price of ₹46.00. The company is currently not paying meaningful dividends.

Last Updated: April 2, 2026, 2:41 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: | NSE:
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Banka Bioloo Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE